Medidata unveils new randomization and trial supply management solution
Medidata Solutions has unveiled Medidata Balance, a randomization and trial supply management (RTSM) technology.
The new solution provides the block randomization methodology, to assign newly enrolled patients to a treatment group, in addition to the allocation methodology.
Balance offers sponsors built-in simulation to test the quality of the balance achieved across the sites, strata and factors, as well as the entire study.
With Balance's new permuted block capability, the simulator can also be used to compare randomization results of dynamic allocation against block, the company said.
The new technology helps site staff access one integrated system to enroll subjects in treatment arms, receive treatment instructions and capture patient data.
Medidata president Glen de Vries said: "With the broader capabilities in Balance's new version, sponsors and CROs can now choose either permuted block or dynamic allocation randomization, within our low-risk, easy-to-deploy and easy-to-use cloud-based randomization solution."
Drug Research Drug Delivery Drug Discovery & Development
Contract Research & Services Clinical Trials Contract Research Contract Services
Automation IT & Software Laboratory Instrumentation
Inward Investment Packaging Regulatory Affairs
This report is a crucial resource for industry executives and anyone looking to access key information about "Shire Plc" The report utilizes a wide range of primary and secondary sources, which are analyzed and presented in a consistent and easily accessible format. ICD Research strictly follows a standardized research methodology to ensure high levels of data quality and these characteristics guarantee a unique report. Buy online from $0